Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 223 entries
Sorted by: Best Match Show Resources per page
Preservation of organic matter in marine sediments by inner-sphere interactions with reactive iron.

Scientific reports

Barber A, Brandes J, Leri A, Lalonde K, Balind K, Wirick S, Wang J, Gélinas Y.
PMID: 28336935
Sci Rep. 2017 Mar 23;7(1):366. doi: 10.1038/s41598-017-00494-0.

Interactions between organic matter and mineral matrices are critical to the preservation of soil and sediment organic matter. In addition to clay minerals, Fe(III) oxides particles have recently been shown to be responsible for the protection and burial of...

Cite
Barber A, Brandes J, Leri A, et al. Preservation of organic matter in marine sediments by inner-sphere interactions with reactive iron. Sci Rep. 2017;7(1):366doi: 10.1038/s41598-017-00494-0.
Barber, A., Brandes, J., Leri, A., Lalonde, K., Balind, K., Wirick, S., Wang, J., & Gélinas, Y. (2017). Preservation of organic matter in marine sediments by inner-sphere interactions with reactive iron. Scientific reports, 7(1), 366. https://doi.org/10.1038/s41598-017-00494-0
Barber, Andrew, et al. "Preservation of organic matter in marine sediments by inner-sphere interactions with reactive iron." Scientific reports vol. 7,1 (2017): 366. doi: https://doi.org/10.1038/s41598-017-00494-0
Barber A, Brandes J, Leri A, Lalonde K, Balind K, Wirick S, Wang J, Gélinas Y. Preservation of organic matter in marine sediments by inner-sphere interactions with reactive iron. Sci Rep. 2017 Mar 23;7(1):366. doi: 10.1038/s41598-017-00494-0. PMID: 28336935; PMCID: PMC5428421.
Copy Download .nbib Format: NLM
Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002).

Veterinary and comparative oncology

Endicott MM, Charney SC, McKnight JA, Loar AS, Barger AM, Bergman PJ.
PMID: 19754799
Vet Comp Oncol. 2007 Mar;5(1):31-7. doi: 10.1111/j.1476-5829.2006.00115.x.

Bone marrow aspiration for routine staging of canine cutaneous mast cell tumour is not consistently performed, and the overall incidence of bone marrow infiltration and predictive value of the complete blood count (CBC) is unknown. This study evaluated a...

Cite
Endicott MM, Charney SC, McKnight JA, et al. Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002). Vet Comp Oncol. 2007;5(1):31-7doi: 10.1111/j.1476-5829.2006.00115.x.
Endicott, M. M., Charney, S. C., McKnight, J. A., Loar, A. S., Barger, A. M., & Bergman, P. J. (2007). Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002). Veterinary and comparative oncology, 5(1), 31-7. https://doi.org/10.1111/j.1476-5829.2006.00115.x
Endicott, M M, et al. "Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002)." Veterinary and comparative oncology vol. 5,1 (2007): 31-7. doi: https://doi.org/10.1111/j.1476-5829.2006.00115.x
Endicott MM, Charney SC, McKnight JA, Loar AS, Barger AM, Bergman PJ. Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours: 157 cases (1999-2002). Vet Comp Oncol. 2007 Mar;5(1):31-7. doi: 10.1111/j.1476-5829.2006.00115.x. PMID: 19754799.
Copy Download .nbib Format: NLM
CMAJ covers.

Canadian Medical Association journal

Barber A, Joubert M, Nabwangu JF.
PMID: 20314009
Can Med Assoc J. 1983 Dec 15;129(12):1261.

No abstract available.

Cite
Barber A, Joubert M, Nabwangu JF. CMAJ covers. Can Med Assoc J. 1983;129(12):1261
Barber, A., Joubert, M., & Nabwangu, J. F. (1983). CMAJ covers. Canadian Medical Association journal, 129(12), 1261.
Barber, A, et al. "CMAJ covers." Canadian Medical Association journal vol. 129,12 (1983): 1261.
Barber A, Joubert M, Nabwangu JF. CMAJ covers. Can Med Assoc J. 1983 Dec 15;129(12):1261. PMID: 20314009; PMCID: PMC1875692.
Copy Download .nbib Format: NLM
Chemical structure and sympathomimetic action of amines.

The Journal of physiology

Barger G, Dale HH.
PMID: 16993040
J Physiol. 1910 Oct 11;41(1):19-59. doi: 10.1113/jphysiol.1910.sp001392.

No abstract available.

Cite
Barger G, Dale HH. Chemical structure and sympathomimetic action of amines. J Physiol. 1910;41(1):19-59doi: 10.1113/jphysiol.1910.sp001392.
Barger, G., & Dale, H. H. (1910). Chemical structure and sympathomimetic action of amines. The Journal of physiology, 41(1), 19-59. https://doi.org/10.1113/jphysiol.1910.sp001392
Barger, G, and Dale, H H. "Chemical structure and sympathomimetic action of amines." The Journal of physiology vol. 41,1 (1910): 19-59. doi: https://doi.org/10.1113/jphysiol.1910.sp001392
Barger G, Dale HH. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1):19-59. doi: 10.1113/jphysiol.1910.sp001392. PMID: 16993040; PMCID: PMC1513032.
Copy Download .nbib Format: NLM
FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN.

The Journal of clinical investigation

Greenwood WF, Barger AC, Dipalma JR, Stokes J, Smith LH.
PMID: 16695541
J Clin Invest. 1948 Mar;27(2):187-97. doi: 10.1172/JCI101933.

No abstract available.

Cite
Greenwood WF, Barger AC, Dipalma JR, et al. FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. J Clin Invest. 1948;27(2):187-97doi: 10.1172/JCI101933.
Greenwood, W. F., Barger, A. C., Dipalma, J. R., Stokes, J., & Smith, L. H. (1948). FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. The Journal of clinical investigation, 27(2), 187-97. https://doi.org/10.1172/JCI101933
Greenwood, W F, et al. "FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN." The Journal of clinical investigation vol. 27,2 (1948): 187-97. doi: https://doi.org/10.1172/JCI101933
Greenwood WF, Barger AC, Dipalma JR, Stokes J, Smith LH. FACTORS AFFECTING THE APPEARANCE AND PERSISTENCE OF VISIBLE CUTANEOUS REACTIVE HYPEREMIA IN MAN. J Clin Invest. 1948 Mar;27(2):187-97. doi: 10.1172/JCI101933. PMID: 16695541; PMCID: PMC439490.
Copy Download .nbib Format: NLM
Note on some Experiments with Glyoxaline Derivatives.

The Biochemical journal

Barger G, Dakin HD.
PMID: 16742647
Biochem J. 1916 Oct;10(3):376-81. doi: 10.1042/bj0100376.

No abstract available.

Cite
Barger G, Dakin HD. Note on some Experiments with Glyoxaline Derivatives. Biochem J. 1916;10(3):376-81doi: 10.1042/bj0100376.
Barger, G., & Dakin, H. D. (1916). Note on some Experiments with Glyoxaline Derivatives. The Biochemical journal, 10(3), 376-81. https://doi.org/10.1042/bj0100376
Barger, G, and Dakin, H D. "Note on some Experiments with Glyoxaline Derivatives." The Biochemical journal vol. 10,3 (1916): 376-81. doi: https://doi.org/10.1042/bj0100376
Barger G, Dakin HD. Note on some Experiments with Glyoxaline Derivatives. Biochem J. 1916 Oct;10(3):376-81. doi: 10.1042/bj0100376. PMID: 16742647; PMCID: PMC1258746.
Copy Download .nbib Format: NLM
The Synthesis of Racemic Pr-2-Methyltryptophan.

The Biochemical journal

Barger G, Ewins AJ.
PMID: 16742723
Biochem J. 1917 May;11(1):58-63. doi: 10.1042/bj0110058.

No abstract available.

Cite
Barger G, Ewins AJ. The Synthesis of Racemic Pr-2-Methyltryptophan. Biochem J. 1917;11(1):58-63doi: 10.1042/bj0110058.
Barger, G., & Ewins, A. J. (1917). The Synthesis of Racemic Pr-2-Methyltryptophan. The Biochemical journal, 11(1), 58-63. https://doi.org/10.1042/bj0110058
Barger, G, and Ewins, A J. "The Synthesis of Racemic Pr-2-Methyltryptophan." The Biochemical journal vol. 11,1 (1917): 58-63. doi: https://doi.org/10.1042/bj0110058
Barger G, Ewins AJ. The Synthesis of Racemic Pr-2-Methyltryptophan. Biochem J. 1917 May;11(1):58-63. doi: 10.1042/bj0110058. PMID: 16742723; PMCID: PMC1258805.
Copy Download .nbib Format: NLM
A new synthesis of methionine.

The Biochemical journal

Barger G, Weichselbaum TE.
PMID: 16744707
Biochem J. 1931;25(4):997-1000. doi: 10.1042/bj0250997.

No abstract available.

Cite
Barger G, Weichselbaum TE. A new synthesis of methionine. Biochem J. 1931;25(4):997-1000doi: 10.1042/bj0250997.
Barger, G., & Weichselbaum, T. E. (1931). A new synthesis of methionine. The Biochemical journal, 25(4), 997-1000. https://doi.org/10.1042/bj0250997
Barger, G, and Weichselbaum, T E. "A new synthesis of methionine." The Biochemical journal vol. 25,4 (1931): 997-1000. doi: https://doi.org/10.1042/bj0250997
Barger G, Weichselbaum TE. A new synthesis of methionine. Biochem J. 1931;25(4):997-1000. doi: 10.1042/bj0250997. PMID: 16744707; PMCID: PMC1260722.
Copy Download .nbib Format: NLM
Novel developments with selective, non-peptidic kappa-opioid receptor agonists.

Expert opinion on investigational drugs

Barber A, Gottschlich R.
PMID: 15989506
Expert Opin Investig Drugs. 1997 Oct;6(10):1351-68. doi: 10.1517/13543784.6.10.1351.

Despite the recent introduction of a number of new compounds, there has of late been a cooling of interest by pharmaceutical companies in the development of centrally-active, selective kappa opioid agonists for therapeutic purposes. This is reflected in the...

Cite
Barber A, Gottschlich R. Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Expert Opin Investig Drugs. 1997;6(10):1351-68doi: 10.1517/13543784.6.10.1351.
Barber, A., & Gottschlich, R. (1997). Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Expert opinion on investigational drugs, 6(10), 1351-68. https://doi.org/10.1517/13543784.6.10.1351
Barber, A, and Gottschlich, R. "Novel developments with selective, non-peptidic kappa-opioid receptor agonists." Expert opinion on investigational drugs vol. 6,10 (1997): 1351-68. doi: https://doi.org/10.1517/13543784.6.10.1351
Barber A, Gottschlich R. Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Expert Opin Investig Drugs. 1997 Oct;6(10):1351-68. doi: 10.1517/13543784.6.10.1351. PMID: 15989506.
Copy Download .nbib Format: NLM
Ergotoxine and some other Constituents of Ergot.

The Biochemical journal

Barger G, Dale HH.
PMID: 16742070
Biochem J. 1907;2(5):240-99. doi: 10.1042/bj0020240.

No abstract available.

Cite
Barger G, Dale HH. Ergotoxine and some other Constituents of Ergot. Biochem J. 1907;2(5):240-99doi: 10.1042/bj0020240.
Barger, G., & Dale, H. H. (1907). Ergotoxine and some other Constituents of Ergot. The Biochemical journal, 2(5), 240-99. https://doi.org/10.1042/bj0020240
Barger, G, and Dale, H H. "Ergotoxine and some other Constituents of Ergot." The Biochemical journal vol. 2,5 (1907): 240-99. doi: https://doi.org/10.1042/bj0020240
Barger G, Dale HH. Ergotoxine and some other Constituents of Ergot. Biochem J. 1907;2(5):240-99. doi: 10.1042/bj0020240. PMID: 16742070; PMCID: PMC1276214.
Copy Download .nbib Format: NLM
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial.

BMJ open

Bolland MJ, Barber A, Doughty RN, Grey A, Gamble G, Reid IR.
PMID: 23512838
BMJ Open. 2013 Mar 18;3(3). doi: 10.1136/bmjopen-2012-002334.

OBJECTIVES: In clinical trials, adverse events are usually self-reported but may be adjudicated if serious or of particular interest. After adjudicating cardiovascular events for a 5-year calcium supplement trial, we observed discrepancies between self-reported and verified events. We systematically...

Cite
Bolland MJ, Barber A, Doughty RN, et al. Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ Open. 2013;3(3)doi: 10.1136/bmjopen-2012-002334.
Bolland, M. J., Barber, A., Doughty, R. N., Grey, A., Gamble, G., & Reid, I. R. (2013). Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ open, 3(3), . https://doi.org/10.1136/bmjopen-2012-002334
Bolland, Mark J, et al. "Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial." BMJ open vol. 3,3 (2013). doi: https://doi.org/10.1136/bmjopen-2012-002334
Bolland MJ, Barber A, Doughty RN, Grey A, Gamble G, Reid IR. Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ Open. 2013 Mar 18;3(3). doi: 10.1136/bmjopen-2012-002334. PMID: 23512838; PMCID: PMC3612743.
Copy Download .nbib Format: NLM
JOBDI special edition-introduction.

Journal of ocular biology, diseases, and informatics

Barber A.
PMID: 23527315
J Ocul Biol Dis Infor. 2011 Jun;4(1):1-2. doi: 10.1007/s12177-012-9084-z. Epub 2012 Mar 23.

No abstract available.

Cite
Barber A. JOBDI special edition-introduction. J Ocul Biol Dis Infor. 2012;4(1):1-2doi: 10.1007/s12177-012-9084-z.
Barber, A. (2011). JOBDI special edition-introduction. Journal of ocular biology, diseases, and informatics, 4(1), 1-2. https://doi.org/10.1007/s12177-012-9084-z
Barber, Alistair. "JOBDI special edition-introduction." Journal of ocular biology, diseases, and informatics vol. 4,1 (2011): 1-2. doi: https://doi.org/10.1007/s12177-012-9084-z
Barber A. JOBDI special edition-introduction. J Ocul Biol Dis Infor. 2011 Jun;4(1):1-2. doi: 10.1007/s12177-012-9084-z. Epub 2012 Mar 23. PMID: 23527315; PMCID: PMC3342403.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 223 entries